ArticleAmerican journal of cancer research2026

Comparative efficacy of CDK4/6 inhibitors palbociclib, ribociclib, and abemaciclib in HR

Bo Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.